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The	diversity	and	relatedness	of	100	Shiga	toxin–pro-
ducing Escherichia coli	O91	isolates	from	different	patients	
were examined by multilocus sequence typing. We identi-
fied	10	specific	sequence	types	(ST)	and	4	distinct	clonal	
groups.	ST442	was	significantly	associated	with	hemolytic	
uremic syndrome. 
S
higa  toxin–producing  Escherichia  coli  (STEC)  in-
fections are public health concerns because of the se-
vere illnesses they cause, such as hemorrhagic colitis and 
hemolytic uremic syndrome (HUS) (1). STEC constitute a 
heterogeneous group of bacteria abundant in the reservoir 
and in the environment (2). Transmission routes for human 
STEC infection are numerous and include contact with ani-
mal excreta, person-to-person transmission, and inadvertent 
ingestion of contaminated food and water. Many STEC se-
rotypes have been recovered from humans (3,4). Among 
them, STEC O91 is the most common serogroup isolated 
from adult patients in Germany (5,6). The strains within this 
serogroup appear to be transmitted predominantly by food, 
because 1) food vehicles have been identified as the only 
risk factors for adults with sporadic STEC O91 infection in 
Germany (6); 2) O91 is the second most frequently isolated 
STEC serogroup in routine food samples (5); and 3) O91 
is the only major STEC serogroup with no association be-
tween incidence of human infection and cattle density (7).
Whereas most human disease STEC serogroups pos-
sess, in addition to Shiga toxin, the eae gene encoding the 
adhesin intimin (3,4,8), STEC O91 consistently lack this 
virulence determinant (8,9). Despite frequent isolation of 
STEC O91 from humans, the clonal relatedness of the se-
rotypes of this serogoup is poorly understood. Therefore, 
we investigated 100 human STEC O91 isolates to deter-
mine the clonal structure of STEC O91 and its association 
with disease.
The Study
A total of 100 STEC O91 isolates were obtained from 
1997 through 2007 from patients with HUS (n = 4), bloody 
diarrhea (n = 8), watery diarrhea without visible blood (n = 
79), abdominal cramps without diarrhea (n = 1), or from as-
ymptomatic carriers (n = 8); samples were from  Germany 
(n = 96), Austria (n = 2; Austrian Reference Library, Inns-
bruck, Austria), Finland (n = 1; The National Public Health 
Institute, Helsinki, Finland), and Canada (n = 1; Public 
Health Agency of Canada, Guelph, Ontario, Canada). The 
96 German O91 strains were recovered at the Institute of 
Hygiene, University of Münster, Münster, and the Robert 
Koch Institute, Wernigerode, Germany. The strains includ-
ed all human isolates of this serogroup that were recovered 
during the study period in Germany and for which com-
plete clinical information was available. The strains corre-
spond to all O91 serotypes associated with human diseases 
from sporadic cases in Germany in that interval. Thirty-five 
strains have been described previously (4,8,10).
The age of patients from whom the STEC O91strains 
originated ranged from 4 months to 89 years (median 28 
years, interquartile range 12–38 years). The most severe 
symptom  was  recorded  for  each  patient.  Diarrhea  was 
defined as ≥3 semisolid or liquid stools per day. Bloody 
diarrhea was defined as diarrheal stools containing blood 
visible to the naked eye. HUS was defined as a case of mi-
croangiopathic hemolytic anemia (hematocrit <30% with 
peripheral evidence of intravascular hemolysis), thrombo-
cytopenia (platelet count <150,000/mm3), and renal insuf-
ficiency (serum creatinine concentration greater than the 
upper limit of normal for age) (11). Asymptomatic carri-
ers were apparently healthy persons without diarrhea; their 
stools were submitted as noted above.
Strains  were  isolated  using  Shiga  toxin–encoding 
genes as diagnostic targets (12) and then serotyped phe-
notypically (13). All strains were verified as O91 by using 
PCR targeting wzyO91, a component of the rfb gene cluster 
that synthesizes the O91 antigen (14). Multilocus sequence 
typing (MLST) and phylogenetic analysis were performed 
as described (4). All allelic sequences were deposited in the 
E. coli MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli). 
The minimum spanning tree was generated from all 100 
O91 sequence types (STs) and compared with the HUS-
associated enterohemorrhagic E. coli (HUSEC) collection 
(4) to display the distribution of the STs compared with all 
known STs associated with HUS.
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We tabulated disease severity according to STs. To 
study the relationship between ST442 and disease sever-
ity, patients were categorized into those with HUS, those 
with  bloody  diarrhea,  and,  serving  as  reference  group, 
those with nonbloody diarrhea or those that asymptom-
atically excreted these organisms. Univariate associations 
were computed by using exact logistic regression. p values 
<0.05 were considered statistically significant. STATA re-
lease 10.0 (StataCorp LP, College Station, TX, USA) was 
used for statistical analysis.
The 100 STEC O91 strains resulted in 10 different 
STs. Of these, STs 33 and 442 were most common (63 and 
20 isolates, respectively). Six additional STs (690, 1048, 
1051,  1052,  1053,  1054)  were  single-locus  variants  of 
ST33, indicating their close relationship. The 2 remaining 
STs (641 and 1020) were not closely related to any other 
ST of the serogroup O91 strains. Detailed analysis of the 
7 housekeeping genes used for MLST demonstrated the 
fumC gene sequence alone could differentiate 5 STs of the 
O91 strains. The comparison of all O91 STs with all STEC 
STs and serotypes associated with HUS (HUSEC collec-
tion) is displayed in the Figure.
H antigens associated with O91 were H8 (n = 1), H10 
(n = 2), H14 (n = 52), H21 (n = 20), Hnt (H-antigen non-
typeable) (n = 10), and H– (H-antigen nonmotile) (n = 15). 
In serotype O91:H8, O91:H10, and O91:H21 strains, the 
STs were serotype-specific. However, ST33 and its single- 
locus variants represented all strains of serotypes O91:H14, 
O91: H–, and O91:Hnt.
A single sequence type, ST442, accounting for 20% of 
all strains, was found among each of the four O91 isolates 
from patients with HUS (Table 1), a highly significant as-
sociation (odds ratio [OR] 27.8, 95% confidence interval 
[CI] 3.3–∞, p<0.01; Table 2). ST442 strains were also more 
frequently isolated from patients with bloody diarrhea than 
were strains belonging to other STs (3/20 [15.0%] vs. 5/80 
[6.3%] respectively), but this difference was not statisti-
cally  significant  (Table  2).  The  overall  association  with 
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Figure.	Minimum	spanning	tree	based	on	the	multilocus	sequence	
typing	allelic	profiles	portraying	the	clonal	distribution	of	the	100	
Escherichia coli	O91:H8/H10/H14/H21/H–/Hnt	isolates	(highlighted	
in	 gray)	 associated	 with	 different	 diseases	 in	 relation	 to	 the	
hemolytic uremic syndrome–associated enterohemorrhagic E. coli 
collection. Each dot represents a given sequence type, and the size 
of each circle is proportional to the number of strains analyzed. 
Connecting	lines	show	the	number	of	identical	alleles	between	2	
STs	(thick	black	line,	6	of	7	alleles	identical;	thick	gray	line,	5	alleles	
identical;	thick	dashed	line,	4	alleles	identical;	thin	dashed	lines	of	
increasing length, <3	alleles	identical).
Table 1. Distribution of disease severity	across	10	different	sequence	types	of	100	STEC	O91	strains	isolated	from	humans*	
Most severe symptomof	patients	infected	with	STEC	O91	
ST	(Serotype)	 HUS	(n	=	4)	 BD	(n	=	8)	 D	(n	=	79)	 A	(n	=	9)	 Total no. strains 
ST33	(O91:H14/H
–/Hnt)	 0 5 51 7 63
ST442	(O91:H21)	 4 3 12 1† 20
ST641	(O91:H10)	 0 0 2 0 2
ST690	(O91:H14)	 0 0 8 1 9
ST1020	(O91:H8)	 0 0 1 0 1
ST1048	(O91:H14)	 0 0 1 0 1
ST1051	(O91:H14)	 0 0 1 0 1
ST1052	(O91:H14)	 0 0 1 0 1
ST1053	(O91:H14)	 0 0 1 0 1
ST1054	(O91:Hnt)	 0 0 1 0 1
*ST,	sequence	type;	STEC,	Shiga	toxin–producing	Escherichia coli;	H,	H-antigen	nonmotile	strains;	Hnt,	H-antigen	nontypeable	strains;	HUS,	hemolytic	
uremic	syndrome;	BD,	bloody	diarrhea;	D,	diarrhea	without	visible	blood;	A,	asymptomatic	infection	(1	patient	infected	with	ST442	[STEC	O91:H21]	had	
abdominal	cramps	without	diarrhea).	
†Abdominal	cramps	without	diarrhea.	severe disease, defined as either HUS or bloody diarrhea, 
was strong (OR 7.8, 95% CI 1.83–36.6, p<0.01). Severe 
illness was noted for 7 (35.0%) of 20 patients infected by 
ST442 strains, but only for 5 (6.3%) of 80 patients infected 
by STEC O91 of other STs (Table 2). Patients with bloody 
diarrhea were younger (median age 12 years) than patients 
who  had  mild  or  no  symptoms  (median  age  20  years). 
However, this difference was not observed for the 4 pa-
tients with HUS (median age 21 years); in this instance, 2 
were adults, 1 was 39 months old, and 1 was unknown.
Conclusions
To gain insight into the clonal structure of STEC O91, 
we determined the relatedness of 100 strains isolated from 
patients and correlated the clonal lineage to the clinical 
outcome of the infection. MLST analysis divided the O91 
isolates into 10 different STs, whereas classical serotyping 
identified only 4 complete serotypes (O- and H-antigen). 
Moreover, MLST was able to type all 25 nonmotile (H–) or 
nontypeable (Hnt) O91 strains. The analysis demonstrated 
that the fumC gene from the 7 genes used for MLST was 
the most heterogeneous and enabled strain differentiation 
into 5 different STs, among these ST442. It might therefore 
be a candidate for first-line single-locus sequence typing.
HUS or bloody diarrhea without HUS was significant-
ly associated with ST442, which was represented by sero-
type O91:H21 only. However, Pradel et al. also reported a 
case of HUS associated with an O91:H10 isolate that could 
be differentiated from O91:H21 by using ribotyping (15). 
In our study, known virulence determinants such as cyto-
lethal distending toxin V or Shiga toxin 2d activatable by 
elastase in O91:H21 strains (8,10) might contribute to the 
higher virulence of O91:H21 (ST442). However, further 
studies of the mechanisms behind the emergence of ST442 
in Germany and additional analysis of global O91 isolates 
are needed. With the MLST approach described, trends and 
changes in STEC O91 epidemiology and human infections 
can be carefully surveyed. 
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